BioShares: Subsidiary Obtains New Veterinary Drug Registration Certificate

MetaMuskRat · 2026-03-27T13:37:48+00:00

People's Financial News, March 26 — BioShares(600201) announced on March 26 that the Ministry of Agriculture and Rural Affairs, after review, approved the company's wholly-owned subsidiary Jinyu Youbang Biotechnology (Jiangsu) Co., Ltd. to jointly develop an inactivated vaccine for goose Newcastle disease and poult enteritis (A-VII strain + GPVP3/Bac strain) as a new veterinary drug. This product is used to prevent goose Newcastle disease and poult enteritis. The successful approval of this product further enriches the company's waterfowl vaccine product portfolio, helps strengthen customer loyalty in breeding, and enhances the company's market competitiveness in the waterfowl vaccine field.

MetaMuskRat

2026-03-27 13:37:48

On March 26, People’s Financial News reported that Bio-Pharmaceutical Co., Ltd. (600201) announced on March 26 that the Ministry of Agriculture and Rural Affairs, after review, approved the new veterinary drug developed in collaboration with other units by its wholly-owned subsidiary, Jinyu Youbang Biotechnology (Jiangsu) Co., Ltd., which is the inactivated vaccine for goose Newcastle disease and gosling viral enteritis (A-VII strain + GPVP3/Bac strain). This product is used to prevent goose Newcastle disease and gosling viral enteritis. The successful approval of this product further enriches the company’s product matrix for waterfowl vaccines, helps enhance customer loyalty among breeders, and improves the company’s market competitiveness in the waterfowl vaccine sector.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.